Engitix
is a tissue engineering company that develops tissue and disease-specific human extracellular matrix for drug discovery process... Read moreEngitix
is a tissue engineering company that develops tissue and disease-specific human extracellular matrix for drug discovery process... Read more
News
Jun 25, 2024
Life Care News
Engitix: Engitix appoints two additional international biotech
Apr 14, 2022
Biospectrum Asia
Engitix: Takeda partners with Engitix to to develop new anti-fibrotic therapies
Apr 12, 2022
Endpoints News
Engitix: Backed by billionaire Mike Platt, Engitix scores another deal with Takeda to go after IBD
Apr 11, 2022
FierceBiotech
Engitix: With $300M up for grabs, Engitix helps Takeda dig into extracellular matrix in search of IBD drugs
Jan 20, 2022
PharmaLive
Engitix: Engitix Nets $54 Million for Human Extracellular Matrix Drug Targets
Jan 19, 2022
LaingBuisson
Engitix: Italy: Domp signs strategic collaboration with Engitix and joins Series A for Engitix
May 04, 2021
FinanzNachrichten
ENGITIX: Engitix Therapeutics appoints Dr Mike Burbridge as VP Oncology and Immuno-oncology
Dec 15, 2020
FinanzNachrichten
ENGITIX: Engitix Ltd: Engitix Therapeutics to Relocate Headquarters to New Life Sciences Cluster, White City Place
Sep 17, 2020
Pharamceutical Technology
ENGITIX: Takeda bets on Engitix's ECM drug discovery platform for liver fibrosis
Sep 01, 2020
Global Legal Chronicle
ENGITIX: Engitix Ltd's Collaboration And Licensing Agreement With Takeda